Clinical Trial Update: Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population [Phase 3]

View source ↗

Summary

A Phase 3 efficacy and safety study evaluating sibutramine for overweight adults in Malaysia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Meridia (sibutramine)

Snippet

Sponsor: Abbott | Conditions: Obesity | Phase 3 | Status: COMPLETED